GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study.


BACKGROUND Biomarker levels in blood after traumatic brain injury (TBI) may offer diagnostic and prognostic tools in addition to clinical indices. This study aims to validate glial fibrillary acidic protein (GFAP) and S100B concentrations in blood as outcome predictors of TBI using cutoff levels of 1.5 μg/L for GFAP and 1.13 μg/L for S100B from a previous… (More)
DOI: 10.1212/WNL.0b013e3181fd62d2


  • Presentations referencing similar topics